Background: Zika virus (ZIKV) is an arbovirus that belongs to family Flaviviridae. The virus has emerged as a global threat and no FDA approved vaccine is available, so an efficient vaccine needs to be designed in order to prevent the infection. Computationally designed vaccines can be used for broad-spectrum therapeutics as they can evoke response against viral infections. In the current study, we have predicted antigenic promiscuous T cell epitopes from Zika virus polyprotein using a range of immune-informatics tools and servers.
Background
Zika virus (ZIKV) family Flaviviridae that has almost 53 known viruses that are single-stranded positive polarity RNA viruses (Huhtamo et al., 2009; Malone et al., 2016) . A mosquito-borne flavivirus is a large group of viruses that are distinguished phylogenetically on the basis of disease transmission and hemorrhagic complications mediated by Aedes genus of mosquito (Gaunt et al., 2001) . Previously, seven groups of mosquito-borne flavivirus were recognized, namely Dengue, Aroa, Kokobera, Japanese encephalitis, Yellow fever, Spondweni, and Ntaya (Mayo et al., 2003) . Transmission of ZIKV has been associated with mosquitoes mainly by Aedes genus mosquitoes, and Aedes aegypti species is the major vector of its infection in Asia (Boorman & Porterfield, 1956; Malone et al., 2016) .
The RNA of ZIKV is single-stranded and serves as mRNA that has one open reading frame (ORF), the translated polyprotein of which further cleaves to form a membrane, capsid, envelope and seven non-structural (NS) proteins that mainly include enzymes necessary for viral replication (Kuno & Chang, 2007) . ZIKV can cause serious health threatening issues to the life of newborns so an efficient vaccine or antiviral drugs need to be designed that can target structural as well as non-structural proteins of ZIKV and help in preventing the infection (Chambers et al., 1990; Leyssen, De Clercq & Neyts, 2000) . No FDA approved treatment or vaccine is available for the cure or prevention of this viral infection. Initially, there was no indication of ZIKV's involvement in disease progression, however, serosurvey data suggested that 6.1% of ZIKV antibodies were present in the residents of Uganda which revealed frequent manifestation of infection (Dick, Kitchen & Haddow, 1952) . For about 70 years from the first isolation, ZIKV remained in obscurity, then within the span of one year it emerged as a global threat and spread from Pacific Island to Brazil and later throughout the states of America (Fauci & Morens, 2016) . WHO (World Health Organization) professed ZIKV infection as a global emergency to public well-being due to the alarming situation it has caused around the globe (Gulland, 2016) . Pakistan and other South Asian countries are at a risk of ZIKV infection as antibodies were suspected in the healthy individuals; the seroprevelance of ZIKV antibodies in Pakistan has been reported to be 2.3% (Posen et al., 2016) .
Historically, empirical vaccine formulation was the most trusted and widespread method, but due to the emergence of viruses having greater genetic instability and antigenic variance, computational tools are of great importance in designing efficient vaccine candidates (SoriaGuerra et al., 2015) . Computationally designed vaccines can be used for broad-spectrum therapeutics as they can evoke better and increased immune response as compared to the normal viral infection. Typically, in viral infection patients use to have an exposure to a limited number of antigenic and immunogenic components of the pathogens (Sette & Fikes, 2003) . So, by employing strategy of Reverse vaccinology antigenic and immunogenic regions of the whole pathogen can be identified. The computationally predicted T cell epitopes from full-length polyprotein can be used to generate a strong cell-mediated as well as a humoral response against the whole pathogen. Epitope-based vaccines designed using computational biology are more potent and safe and evoke a greater immune response. The natural infection may not necessarily recognize all the epitopes, so the need of the hour is to design an epitope-based vaccine to have greater and more specific T cell response against the MHC-epitope complex (Sette & Fikes, 2003) . Antigen Presenting Cells (APC) showing MHC-epitope complexes activates a repertoire of T cells that recognize these complexes and induce immune responses accordingly (Chen et al., 2000) .
In this study, we have taken an increased number of polyproteins available in databases than previous studies to reveal new antigenic and immunogenic conserved epitopes using multiple specificity of the server. ProPred I determines the affinity of peptides to bind with 47 HLA-I alleles.
The projected peptide sequences were analyzed for their antigenicity using Vaxijen server 2.0 (Doytchinova & Flower, 2007) . The threshold was selected at 0.5 and the antigenic epitopes were taken for further analysis. The epitopes were evaluated for their immunogenic property using immunogenicity tool of IEDB ( http://tools.iedb.org/immunogenicity/) (Calis et al., 2013) . The predicted epitopes from both CTLPred and ProPred I were then shortlisted based on their antigenicity and immunogenicity. 
Prediction of MHC-I binding affinity

Analysis of HLA class II binding T cell epitopes
The consensus polyprotein sequence of ZIKV was submitted to ProPred server (Singh & Raghava, 2001) . ProPred was used at a 3% threshold to predict epitopes for a total of 51 HLA-II alleles. ProPred enables the prediction of binding potential of epitopes for 51 HLA class II alleles.
Like ProPred I server, the default cutoff value provides a compromise between the sensitivity and specificity of the server. The projected peptide sequences were analyzed for their antigenicity using Vaxijen server 2.0 (Doytchinova & Flower, 2007) . The threshold was selected at 0.5 and the antigenic epitopes were taken for further analysis. 
Analysis of MHC-II binding affinity
Prediction of MHC-II interacting epitopes was performed using MHCPred (Guan et al., 2003a,b; Hattotuwagama et al., 2004) . "Amino acids and interaction" model was chosen to calculate numeric values of affinity in -log IC50(M) and IC50. Epitopes having -log IC50 > 6.4 were prioritized and further analyzed.
Identification of homology with human proteome
The peptide sequences were checked for their similarity against the human proteome by performing protein BLAST (accessible at https://blast.ncbi.nlm.nih.gov/Blast.cgi) to determine their harmless use as potential vaccine candidates.
Results
Exploration of CD8 T cell epitopes
A total of 78 MHC-I binding MHC-I binding epitopes are stipulated in Table S1 . All the predicted epitopes were antigenic, immunogenic and lie in the structural and non-structural region of viral polyprotein.
Prediction of MHC-I binding affinity
Immunogenicity of potential epitope depends upon its binding affinity with MHC molecule.
Based on this, 19 epitopes out of 78 predicted epitopes were pooled out. The prioritized epitopes were predicted to have a strong interaction with HLA alleles. The shortlisted epitopes can be seen in Table 1 along with their antigenicity, immunogenicity and affinity score.
In NS2A region out of 6 prioritized epitopes, RLVDPINVV NS2A
1353-61 has maximum antigenicity, however, 10 HLA alleles were predicted to bind with it. Meanwhile, VPRTDNITL NS2A 1290-1298 has a maximum number of interacting HLA alleles so it can target greater HLA population. In NS3 only one epitope has been prioritized i.e. VPNYNLYIM NS3 1778-1786 that has good antigenicity and immunogenicity score. Epitope TPLTLIVAI of NS4B has been predicted by all of the servers and has good antigenicity, immunogenicity, binding affinity as well as promiscuity. All the prioritized epitopes are strong MHC binders as can be seen in Table 1 .
Crystal structures of Envelope, NS3 and NS5 were available and were retrieved from Protein
DataBank (Berman et al., 2006; Sirohi et al., 2016; Tian et al., 2016; Upadhyay et al., 2017) .
Modeled structures of NS2A and NS2B were obtained from Gupta et al (Gupta et al., 2016) .
HLA-I epitopes that were found in models were visualized and colored in chimera, and are shown in Fig. 1 (Pettersen et al., 2004) .
Identification of host homology
All the prioritized epitopes do not have a putative conserved domain in humans. All the promiscuous epitope
Prediction of CD8 T cell epitopes
A total of seventy HLA-II binding antigenic T cell epitopes were projected in the various regions of ZIKV proteins as outlined in Table S2 . Antigenicity score, as well as amino acid position of each epitope, was predicted.
Prediction of MHC-II binding affinity
Among 70 MHC-II binding epitopes, only 66 epitopes have a strong binding affinity with major MHC-II alleles. IC50 and -log IC50 of each shortlisted epitope is illustrated in table 2.
In the Protein C, Protein C 50-58 was predicted to bind 18 MHC class II alleles with high antigenic score i.e. 1.0423. In PrM region, Epitope PrM 277-285 was projected to bind 38 HLA-II alleles. E 677-
685
, with antigenicity score 2.6489, was found to be the most antigenic HLA class II binding epitope according to our analysis. However, it was predicted to bind 9 HLA-II alleles.
Comparatively, E 784-792 was found to bind 16 HLA-II alleles with good antigenic score i.e. 0.5846.
In the NS1 region, epitope NS1 All the prioritized epitopes had >6.3 -log IC50 value which reveals their strong interaction with HLA-II major alleles.
Crystal structures of PrM, Envelope, NS1, NS3, and NS5 were available and were retrieved from Protein DataBank (Berman et al., 2006; Brown et al., 2016; Jain et al., 2016; Sirohi et al., 2016; Upadhyay et al., 2017) . Modeled structures of NS2A, NS2B, NS4A, were obtained from Gupta et al (Gupta et al., 2016) . However, due to the unavailability of high-quality crystal structure or homology model, the structure of NS4B was modeled by Phyre 2 (Kelley et al., 2015) . HLA-II prioritized epitopes were visualized and colored in chimera, and are shown in 
Identification of homology with human proteome
All the shortlisted epitopes were found to be non-homologous with Homo sapiens (taxid 9609).
No putative conserved domain of any epitope was predicted in Humans. The predicted epitopes are safe to use as vaccine candidates.
Discussion
Vaccine development is a long-term high-priced process that lasts for years (Leroux-Roels et al., 2011) . employing modern computational vaccinology, we have developed insight into ZIKV and utilized the information to screen antigenic as well as immunogenic T cell epitopes. These epitopes can be used in a vaccine to combat epidemic infection of ZIKV. The main objective of our analysis was to evaluate T-cell (both MHC-I and MHC-II interacting T cells) epitopes using bioinformatics tools to evoke cell-mediated as well as humoral response using the available genomes at the time of writing. A similar study was conducted in 2013 in which only T cell epitopes from 54 available genomes were taken into account (Dar et al., 2016) . However, the present study is more focused and comprehensive based on 238 genomes. in the surface exposed region (as can be seen in Fig 1 and 2) . Some of the epitopes predicted in our study proved their efficacy after experimental evaluation, these epitopes are indicated in The epitopes analyzed and shortlisted in our study were found to be conserved. They do not bear homology to human proteins, so the epitope-based vaccine is not expected to create any autoimmune or harmful inflammatory responses in the human body. The epitope targeting vaccine is an efficient, promising and widely used strategy to prevent viral and bacterial infections. Epitope-based vaccine developmental studies using in silico approaches are indicated in many studies (Dikhit et al., 2016; Alam et al., 2016) . Vaccine development studies against
Flaviviruses are less because of the natural immunity of animal models toward Flaviviruses.
Hence, the computational prediction of epitopes is an effective method to analyze and report vaccine candidate for Flaviviruses. The antigenic and highly conserved epitopes highlighted in our study can be used to generate a multi-epitope vaccine construct that can elicit a more pronounced response than the individual epitopes.
The work presented here is purely computational and it needs in vitro studies for verification of results and that is the only limitation of our study. Although wet lab validation studies are considered more accurate and reliable, computational approaches have provided sound basis to proceed further (Brusic & Petrovsky, 2005; Vivona et al., 2008; Patronov & Doytchinova, 2013) .
Conclusion
Peptide based vaccines are safe and promising candidates against viral infection. The current study revealed some novel antigenic and promising vaccine candidates from the consensus sequence of 238 genomes of ZIKV. The MHC-I and MHC-II interacting T cell epitopes prioritized in our study can be used to elicit cell mediated and humoral immune response or both.
The shortlisted epitopes present in more than one Flaviviruses can be used to construct broadspectrum vaccine candidate. We believe that methodology followed in this study can be extended to target viruses.
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